Product Overview
Sugammadex | T5326L | TargetMol Chemicals
CAS: 343306-71-8
Smiles: O[C@H]1[C@H](O)[C@@H]2O[C@H]3OC(CSCCC(O)=O)[C@@H](O[C@H]4OC(CSCCC(O)=O)[C@@H](O[C@H]5OC(CSCCC(O)=O)[C@@H](O[C@H]6OC(CSCCC(O)=O)[C@@H](O[C@H]7OC(CSCCC(O)=O)[C@@H](O[C@H]8OC(CSCCC(O)=O)[C@@H](O[C@H]9OC(CSCCC(O)=O)[C@@H](OC1OC2CSCCC(O)=O)[C@@H](O)[C@@H]9O)[C@@H](O)[C@@H]8O)[C@@H](O)[C@@H]7O)[C@@H](O)[C@@H]6O)[C@@H](O)[C@@H]5O)[C@@H](O)[C@@H]4O)[C@@H](O)[C@@H]3O
Formula: C72H112O48S8
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: Sugammadex is an agent for reversal of neuromuscular blockade by the agent rocuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). Sugammadex is a modified γ-cyclodextrin, with a lipophilic core and a hydrophilic periphery. This gamma cyclodextrin has been modified from its natural state by placing eight carboxyl thio ether groups at the sixth carbon positions. These extensions extend the cavity size allowing greater encapsulation of the rocuronium molecule. These negatively charged extensions electrostatically bind to the quaternary nitrogen of the target as well as contribute to the aqueous nature of the cyclodextrin.
Molecular Weight: 2002, 12
